
Immune biomarkers in immunotherapeutic trials for type 1 diabetes: Cui prodest?
Keywords: واکسیناسیون; Type 1 diabetes; Therapy; Immunological strategies antibodies; Antigen; Islet; T cells; Vaccination; ReviewDiabète de type 1; Intervention immunologiques; Traitement; Anticorps; Antigène; Îlot; Cellules T; Vaccination; Revue générale